Symptomatic SARS-CoV2 infections in patients treated in France by hemodialysis in an establishment, or at home or by peritoneal dialysis: Data from the REIN and RDPLF registries

Symptomatic SARS-CoV2 infections in patients treated in France by hemodialysis in an establishment, or at home or by peritoneal dialysis: Data from the REIN and RDPLF registries

Blog Article

In France all patients treated with dialysis are registered in teclado newskill blanco the REIN registry (Epidemiology and Information Network in Nephrology) ; in addition the RDPLF (French Language Peritoneal Dialysis Registry) monitors patients treated at home in French-speaking regions and countries.Asymptomatic patients with a positive SARS-CoV2 test were excluded : the study focused only on patients with symptomatic COVID-19 disease.Data from REIN and RDPLF were used.In total, 3,541 patients were declared symptomatic with COVID-19.

The proportion of patients with symptomatic SAR-coV2 infection was 4.9% in patients treated at home by peritoneal dialysis or hemodialysis and 8.0% in those treated in a dialysis unit.After adjustment for age and comorbidities, being treated at home was associated with a higher risk of mortality.

In conclusion, home treatments could represent a solution for preventing the risk of contamination during the circulation of the virus.On the other hand, the bostik mvp risk of mortality in symptomatic patients at home could be linked to a delay in treatment: rigorous remote organization must be implemented so as not to delay the treatment of patients in the event of infection.